• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Systems biology of immunity to MF59-adjuvanted versus nonadjuvanted trivalent seasonal influenza vaccines in early childhood

tetano

Editor, Senior Moderator
Proc Natl Acad Sci U S A. 2016 Jan 11. pii: 201519690. [Epub ahead of print]
[h=1]Systems biology of immunity to MF59-adjuvanted versus nonadjuvanted trivalent seasonal influenza vaccines in early childhood.[/h] Nakaya HI[SUP]1[/SUP], Clutterbuck E[SUP]2[/SUP], Kazmin D[SUP]3[/SUP], Wang L[SUP]4[/SUP], Cortese M[SUP]3[/SUP], Bosinger SE[SUP]5[/SUP], Patel NB[SUP]6[/SUP], Zak DE[SUP]7[/SUP], Aderem A[SUP]7[/SUP], Dong T[SUP]4[/SUP], Del Giudice G[SUP]8[/SUP], Rappuoli R[SUP]9[/SUP], Cerundolo V[SUP]4[/SUP], Pollard AJ[SUP]2[/SUP], Pulendran B[SUP]10[/SUP], Siegrist CA[SUP]11[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] The dynamics and molecular mechanisms underlying vaccine immunity in early childhood remain poorly understood. Here we applied systems approaches to investigate the innate and adaptive responses to trivalent inactivated influenza vaccine (TIV) and MF59-adjuvanted TIV (ATIV) in 90 14- to 24-mo-old healthy children. MF59 enhanced the magnitude and kinetics of serum antibody titers following vaccination, and induced a greater frequency of vaccine specific, multicytokine-producing CD4[SUP]+[/SUP] T cells. Compared with transcriptional responses to TIV vaccination previously reported in adults, responses to TIV in infants were markedly attenuated, limited to genes regulating antiviral and antigen presentation pathways, and observed only in a subset of vaccinees. In contrast, transcriptional responses to ATIV boost were more homogenous and robust. Interestingly, a day 1 gene signature characteristic of the innate response (antiviral IFN genes, dendritic cell, and monocyte responses) correlated with hemagglutination at day 28. These findings demonstrate that MF59 enhances the magnitude, kinetics, and consistency of the innate and adaptive response to vaccination with the seasonal influenza vaccine during early childhood, and identify potential molecular correlates of antibody responses.


[h=4]KEYWORDS:[/h] MF59; adjuvant; children; influenza vaccine; systems biology

PMID: 26755593 [PubMed - as supplied by publisher] Free full text
 
Back
Top Bottom